204 related articles for article (PubMed ID: 26181021)
1. Regional-Level Correlations in Inappropriate Imaging Rates for Prostate and Breast Cancers: Potential Implications for the Choosing Wisely Campaign.
Makarov DV; Soulos PR; Gold HT; Yu JB; Sen S; Ross JS; Gross CP
JAMA Oncol; 2015 May; 1(2):185-94. PubMed ID: 26181021
[TBL] [Abstract][Full Text] [Related]
2. Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009.
Dinan MA; Mi X; Reed SD; Hirsch BR; Lyman GH; Curtis LH
JAMA Oncol; 2015 May; 1(2):158-66. PubMed ID: 26181015
[TBL] [Abstract][Full Text] [Related]
3. Population-Based Assessment of Determining Treatments for Prostate Cancer.
Chamie K; Williams SB; Hu JC
JAMA Oncol; 2015 Apr; 1(1):60-7. PubMed ID: 26182305
[TBL] [Abstract][Full Text] [Related]
4. Are there regional tendencies toward controversial screening practices? A study of prostate and breast cancer screening in a Medicare population.
Raffin E; Onega T; Bynum J; Austin A; Carmichael D; Bronner K; Goodney P; Hyams ES
Cancer Epidemiol; 2017 Oct; 50(Pt A):68-75. PubMed ID: 28822325
[TBL] [Abstract][Full Text] [Related]
5. Advanced imaging and hospice use in end-of-life cancer care.
Dinan MA; Curtis LH; Setoguchi S; Cheung WY
Support Care Cancer; 2018 Oct; 26(10):3619-3625. PubMed ID: 29728843
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Imaging Use for Patients With Cancer: Opportunities to Enhance Value.
Swisher-McClure S; Bekelman J
JAMA Oncol; 2015 May; 1(2):194-5. PubMed ID: 26181022
[No Abstract] [Full Text] [Related]
7. Physician-Driven Variation in Nonrecommended Services Among Older Adults Diagnosed With Cancer.
Lipitz-Snyderman A; Sima CS; Atoria CL; Elkin EB; Anderson C; Blinder V; Tsai CJ; Panageas KS; Bach PB
JAMA Intern Med; 2016 Oct; 176(10):1541-1548. PubMed ID: 27533635
[TBL] [Abstract][Full Text] [Related]
8. Choosing wisely: prevalence and correlates of low-value health care services in the United States.
Colla CH; Morden NE; Sequist TD; Schpero WL; Rosenthal MB
J Gen Intern Med; 2015 Feb; 30(2):221-8. PubMed ID: 25373832
[TBL] [Abstract][Full Text] [Related]
9. Overuse of early peripheral vascular interventions for claudication.
Hicks CW; Holscher CM; Wang P; Black JH; Abularrage CJ; Makary MA
J Vasc Surg; 2020 Jan; 71(1):121-130.e1. PubMed ID: 31208940
[TBL] [Abstract][Full Text] [Related]
10. Use of posttreatment imaging and biomarkers in survivors of early-stage breast cancer: Inappropriate surveillance or necessary care?
Hahn EE; Tang T; Lee JS; Munoz-Plaza CE; Shen E; Rowley B; Maeda JL; Mosen DM; Ruckdeschel JC; Gould MK
Cancer; 2016 Mar; 122(6):908-16. PubMed ID: 26650715
[TBL] [Abstract][Full Text] [Related]
11. Surveillance testing among survivors of early-stage breast cancer.
Keating NL; Landrum MB; Guadagnoli E; Winer EP; Ayanian JZ
J Clin Oncol; 2007 Mar; 25(9):1074-81. PubMed ID: 17369571
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer imaging trends after a nationwide effort to discourage inappropriate prostate cancer imaging.
Makarov DV; Loeb S; Ulmert D; Drevin L; Lambe M; Stattin P
J Natl Cancer Inst; 2013 Sep; 105(17):1306-13. PubMed ID: 23853055
[TBL] [Abstract][Full Text] [Related]
13. Association Between Guideline-Discordant Prostate Cancer Imaging Rates and Health Care Service Among Veterans and Medicare Recipients.
Makarov DV; Ciprut S; Walter D; Kelly M; Gold HT; Zhou XH; Sherman SE; Braithwaite RS; Gross C; Zeliadt S
JAMA Netw Open; 2018 Aug; 1(4):e181172. PubMed ID: 30646111
[TBL] [Abstract][Full Text] [Related]
14. The association of Carotid Revascularization Endarterectomy versus Stent Trial (CREST) and Centers for Medicare and Medicaid Services Carotid Guideline Publication on utilization and outcomes of carotid stenting among "high-risk" patients.
Salzler GG; Farber A; Rybin DV; Doros G; Siracuse JJ; Eslami MH
J Vasc Surg; 2017 Jul; 66(1):104-111.e1. PubMed ID: 28502543
[TBL] [Abstract][Full Text] [Related]
15. Urologist-Level Correlation in the Use of Observation for Low- and High-Risk Prostate Cancer.
Tyson MD; Graves AJ; O'Neil B; Barocas DA; Chang SS; Penson DF; Resnick MJ
JAMA Surg; 2017 Jan; 152(1):27-34. PubMed ID: 27653425
[TBL] [Abstract][Full Text] [Related]
16. Variation in use of androgen suppression with external-beam radiotherapy for nonmetastatic prostate cancer.
Swisher-McClure S; Pollack CE; Christodouleas JP; Guzzo TJ; Haas NB; Vapiwala N; Bekelman JE
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):8-15. PubMed ID: 22079721
[TBL] [Abstract][Full Text] [Related]
17. The population level prevalence and correlates of appropriate and inappropriate imaging to stage incident prostate cancer in the medicare population.
Makarov DV; Desai RA; Yu JB; Sharma R; Abraham N; Albertsen PC; Penson DF; Gross CP
J Urol; 2012 Jan; 187(1):97-102. PubMed ID: 22088337
[TBL] [Abstract][Full Text] [Related]
18. The Impact of the Choosing Wisely Campaign in Urology.
Welk B; Winick-Ng J; McClure JA; Lorenzo AJ; Kulkarni G; Ordon M
Urology; 2018 Jun; 116():81-86. PubMed ID: 29572056
[TBL] [Abstract][Full Text] [Related]
19. Impact of choosing wisely on imaging in men with newly diagnosed prostate cancer.
Lange SM; Choudry MM; Hunt TC; Ambrose JP; Haaland BA; Lowrance WT; Hanson HA; O'Neil BB
Urol Oncol; 2023 Jan; 41(1):48.e19-48.e26. PubMed ID: 36307366
[TBL] [Abstract][Full Text] [Related]
20. The cost implications of prostate cancer screening in the Medicare population.
Ma X; Wang R; Long JB; Ross JS; Soulos PR; Yu JB; Makarov DV; Gold HT; Gross CP
Cancer; 2014 Jan; 120(1):96-102. PubMed ID: 24122801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
